Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
2020 | |||
2019 | |||
Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial Proceeding/Conference:San Antonio Breast Cancer Congress (SABCS) | 2017 |